Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein

The Journal of Urology
Craig G RogersChristian P Pavlovich

Abstract

We assessed the feasibility of a novel urinary test for prostate cancer based on the presence of alpha methylacyl coenzyme A racemase (AMACR) protein in voided urine specimens obtained after prostate biopsy. Clean catch voided urine specimens were prospectively collected from 26 consecutive men immediately after transrectal ultrasound guided prostate biopsy for suspected malignancy. The presence of AMACR was evaluated in a blinded manner by Western blot analysis and correlated with biopsy results and patient clinical information. AMACR was detected in the urine in 18 of 26 patients (69%). AMACR was detected in all 12 patients with biopsy confirmed adenocarcinoma of the prostate (100% sensitivity, 95% CI 75 to 100), in 5 of 12 with no evidence of cancer on biopsy (58% specificity, 95% CI 29 to 78) and in 1 of 2 (50%, 95% CI 3 to 80) with atypia on biopsy. Overall AMACR detection was associated with cancer status by prostate biopsy in 21 of 26 patients (86%). We report the feasibility of a novel, noninvasive, nonprostate specific antigen based molecular approach to detect prostate cancer in voided urine. To our knowledge this is the first report of AMACR protein detection in the urine of patients with prostate cancer. A screening...Continue Reading

References

Oct 9, 2001·Epidemiologic Reviews·L N Kolonel
Oct 31, 2001·The American Journal of Surgical Pathology·Z JiangG R Fanger
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Mark A RubinArul M Chinnaiyan
May 7, 2002·The Journal of Urology·Chris H ChonJoseph C Presti
Jul 20, 2002·The American Journal of Surgical Pathology·Ximing J YangZhong Jiang
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 29, 2003·The American Journal of Surgical Pathology·Cristina Magi-GalluzziJonathan I Epstein

❮ Previous
Next ❯

Citations

Dec 15, 2007·Molecular Diagnosis & Therapy·Prateek Mendiratta, Phillip G Febbo
Jan 14, 2012·Analytical and Bioanalytical Chemistry·Xue GaoXingguang Su
Aug 11, 2007·World Journal of Urology·Eric Schiffer
May 5, 2005·Current Urology Reports·Javier HernandezIan M Thompson
Feb 17, 2006·Current Urology Reports·Peter S Nelson, Bruce Montgomery
Apr 18, 2009·Current Urology Reports·Michael C Risk, Daniel W Lin
Dec 4, 2008·Asian Journal of Andrology·Sachin Agrawal, William D Dunsmuir
Mar 26, 2013·Asian Journal of Andrology·Daphne Hessels, Jack A Schalken
Aug 5, 2009·Prostate Cancer and Prostatic Diseases·T JamaspishviliJ Bouchal
Jul 27, 2011·Prostate Cancer and Prostatic Diseases·T JamaspishviliJ Bouchal
Oct 15, 2005·The American Journal of Surgical Pathology·Adrian GologanRajiv Dhir
Oct 25, 2008·Annual Review of Medicine·Danil V MakarovAlan W Partin
Nov 28, 2007·Annual Review of Pathology·Scott A TomlinsArul M Chinnaiyan
Apr 16, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David Z QianTomasz M Beer
Sep 2, 2010·PloS One·Regina Berretta, Pablo Moscato
Jul 3, 2013·Archives of Pathology & Laboratory Medicine·Amy G ZhouZhong Jiang
Oct 19, 2012·Biomarkers in Medicine·Girish Sardana, Eleftherios P Diamandis
May 17, 2014·Asian Journal of Andrology·Min QuYing-Hao Sun
Nov 10, 2006·BJU International·Michelle R DownesR William G Watson
Sep 7, 2013·Biomolecules & Therapeutics·Hoon Young Kong, Jonghoe Byun
Jul 17, 2012·Urologic Oncology·Raj P PalMasood A Khan
Jan 22, 2008·The Journal of Urology·Yoh MatsuokaKazunori Kihara
Dec 2, 2006·Urologic Oncology·Timothy J BradfordArul M Chinnaiyan
Sep 2, 2006·Critical Reviews in Oncology/hematology·H G van der Poel
Jun 10, 2017·Expert Review of Molecular Diagnostics·Silvia GasparriniRodolfo Montironi
Jan 1, 2010·Cancers·Raymond A ClarkeRobert A Gardiner
Aug 22, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·Kazutoshi Fujita, Norio Nonomura
Mar 7, 2008·Proteomics. Clinical Applications·Dan TheodorescuHarald Mischak
Jan 13, 2010·Nature Reviews. Urology·Guillaume Ploussard, Alexandre de la Taille
Oct 20, 2006·Critical Reviews in Clinical Laboratory Sciences·Qinghua FengNancy B Kiviat
Jan 19, 2019·Prostate Cancer and Prostatic Diseases·Jillian N EskraJun Luo
Oct 18, 2008·Clinical Chemistry·Girish SardanaEleftherios P Diamandis
Mar 16, 2007·Expert Review of Medical Devices·Nicholas J FitzsimonsJudd W Moul
May 20, 2015·The International Journal of Biological Markers·Wiktor Dariusz SrokaMichał Piotr Marszałł
Dec 4, 2019·Cancer Control : Journal of the Moffitt Cancer Center·Jin JiYinghao Sun
Sep 11, 2018·Oncotarget·Andrej JedinakMarsha A Moses

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.